← All trials
NCT00453401
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2007
- Primary completion
- Dec 1, 2007
- Completion date
- Dec 1, 2007
- First posted
- —
- Last posted
- —
- Enrollment
- 1000
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- BlueWillow BiologicsLead sponsor
- Derm Research, PLLCOverall official - principal investigator
- Research Across AmericaOverall official - principal investigator
- Front Range Clinical ResearchOverall official - principal investigator
- Bock Clinical Research IncorporatedOverall official - principal investigator
- Benchmark ResearchOverall official - principal investigator
- Suncoast Clinical ResearchOverall official - principal investigator
- Omega Medical ResearchOverall official - principal investigator
- Westover Heights ClinicOverall official - principal investigator
- Derm Research IncorporatedOverall official - principal investigator
- Wenatchee Valley Medical CenterOverall official - principal investigator
- Clinical Research of West FloridaOverall official - principal investigator
- Advance HealthcareOverall official - principal investigator
- Westlake Medical ResearchOverall official - principal investigator
- New River Valley Research InstituteOverall official - principal investigator
- AMR Advanced Medical Research GmbHOverall official - principal investigator
- BlueWillow BiologicsOverall official - principal investigator
- J&S Studies Inc.Overall official - principal investigator
- Medical Affiliated Research Center, Inc.Overall official - principal investigator
- Wake Research AssociatesOverall official - principal investigator
- Advanced Clinical Research Inc.Overall official - principal investigator
- Coastal Carolina ResearchOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.